×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [62]
内容类型
期刊论文 [47]
会议论文 [15]
发表日期
2019 [2]
2018 [7]
2017 [7]
2016 [14]
2015 [27]
2014 [4]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共62条,第1-10条
帮助
限定条件
专题:中国医学科学院 北京协和医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Monitoring the cytogenetic architecture of minimal residual plasma cells indicates therapy-induced clonal selection in multiple myeloma
期刊论文
2019
作者:
An Gang
;
Yan Yuting
;
Xu Yan
;
Mao Xuehan
;
Liu Jiahui
收藏
  |  
浏览/下载:71/0
  |  
提交时间:2020/01/03
The impact of response kinetics for multiple myeloma in the era of novel agents
期刊论文
2019, 卷号: 3, 期号: 19, 页码: 2895-2904
作者:
Yan Yuting
;
Mao Xuehan
;
Liu Jiahui
;
Fan Huishou
;
Du Chenxing
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2020/01/03
Del17p does not always significantly influence the survival of B-cell chronic lymphoproliferative disorders
期刊论文
2018, 卷号: 9, 期号: 3, 页码: 3353-3364
作者:
Yi, Shuhua
;
Li, Zengjun
;
Zou, Dehui
;
Xiong, Wenjie
;
Li, Heng
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/03
B-cell chronic lymphoproliferative disorders
chronic lymphocytic leukemia
cytogenetic aberration
del 17p
prognosis
Tolerance, Kinetics, and Depth of Response for Subcutaneous Versus Intravenous Administration of Bortezomib Combination in Chinese Patients With Newly Diagnosed Multiple Myeloma
期刊论文
2018, 卷号: 18, 期号: 6, 页码: 422-430
作者:
Xu, Yan
;
Deng, Shuhui
;
Mao, Xuehan
;
An, Gang
;
Li, Zengjun
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2020/01/03
Bortezomib
Intravenous administration
Multiple myeloma
Response
Subcutaneous administration
Plerixafor and granulocyte-colony-stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non-Hodgkin's lymphoma: a randomized Phase 3 study
期刊论文
2018, 卷号: 58, 期号: 1, 页码: 81-87
作者:
Zhu, Jun
;
Huang, Huiqiang
;
Chen, Huan
;
Zhang, Xi
;
Li, Zengjun
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2020/01/03
Preliminary Results from a Phase I, First-in-Human Study of YY-20394, a Highly Selective and Highly Potent PI3K delta Inhibitor, in Patients with Relapsed or Refractory B-Cell Malignancies
会议论文
BLOOD, 2018-11-29
作者:
Qi, Junyuan
;
Song, Yuqin
;
Jiang, Bo
;
Li, Jianyong
;
Tu, Meifeng
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2020/01/03
Preliminary Results from a Phase I, First-in-Human Study of YY-20394, a Highly Selective and Highly Potent PI3K delta Inhibitor, in Patients with Relapsed or Refractory B-Cell Malignancies
期刊论文
2018, 卷号: 132
作者:
Qi, Junyuan
;
Song, Yuqin
;
Jiang, Bo
;
Li, Jianyong
;
Tu, Meifeng
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/03
The Role of Molacular Genetic Examination in Differential Diagnosis and Prognostic Prediction in Patints with B-Cell Chronic Lymphoproliferative Disorders: A Restrospective Study of 1592 Patients
会议论文
BLOOD, 2018-11-29
作者:
Yan, Yuting
;
Xiong, Wenjie
;
Yi, Shuhua
;
Li Zengjun
;
Zou, Dehui
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/03
The Role of Molacular Genetic Examination in Differential Diagnosis and Prognostic Prediction in Patints with B-Cell Chronic Lymphoproliferative Disorders: A Restrospective Study of 1592 Patients
期刊论文
2018, 卷号: 132
作者:
Yan, Yuting
;
Xiong, Wenjie
;
Yi, Shuhua
;
Li Zengjun
;
Zou, Dehui
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia
期刊论文
2017, 卷号: 130, 期号: 2, 页码: 135-U14
作者:
Li Heng
;
Yi Shuhua
;
Xiong Wenjie
;
Liu Huimin
;
Lyu Rui
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/03
17p Deletion
Chronic Lymphocytic Leukemia
Immunoglobulin Heavy Chain Variable Mutation
Prognostic Index
Time to First Treatment
©版权所有 ©2017 CSpace - Powered by
CSpace